These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 979658)

  • 1. The effects of glucagon administration to nondiabetics and diabetics.
    Unger RH; Aydin I; Nakabayashi H; Srikant CB; Raskin P
    Metabolism; 1976 Nov; 25(11 Suppl 1):1523-6. PubMed ID: 979658
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin dependent diabetics.
    Ferlito S; Del Campo F; Di Vincenzo S; Damante G; Coco R; Branca S; Fichera C
    Farmaco Sci; 1983 Apr; 38(4):248-54. PubMed ID: 6345193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of endogenous glucagon and insulin in unstable diabetes.
    Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS
    Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus.
    Starke A; Keck E; Berger M; Zimmermann H
    Diabetologia; 1981 May; 20(5):547-52. PubMed ID: 7026328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects.
    Turco G; Brossa C; D'Alberto M; Regis G; Segre G; Bianchi E; Bruni B; Gamba S
    Diabetes; 1981 Aug; 30(8):685-93. PubMed ID: 7018972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free insulin, C-peptide and glucagon profiles in insulin dependent diabetes mellitus.
    Scott RS; Espiner EA; Donald RA; Ellis MJ
    Aust N Z J Med; 1980 Apr; 10(2):146-50. PubMed ID: 6992759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics.
    Wajngot A; Roovete A; Vranić M; Luft R; Efendić S
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4432-6. PubMed ID: 6750603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma insulin and C-peptide responses to oral glucose in newly diagnosed diabetics in north-western Tanzania.
    Ahren B; Corrigan CB; Alberti KG
    East Afr Med J; 1988 Dec; 65(12):847-51. PubMed ID: 3069450
    [No Abstract]   [Full Text] [Related]  

  • 10. C-peptide measurement and its clinical usefulness: a review.
    Bonser AM; Garcia-Webb P
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):200-6. PubMed ID: 7025733
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood serum levels of C-peptide and insulin in diabetics and healthy persons after intravenous administration of glucagon and glucose].
    Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Krókewski AS
    Pol Arch Med Wewn; 1980 Sep; 64(3):229-38. PubMed ID: 7003563
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin, C-peptide, and proinsulin in nondiabetics and insulin-treated diabetics. Characterization of the proinsulin in insulin-treated diabetics.
    Heding LG
    Diabetes; 1978; 27 Suppl 1():178-83. PubMed ID: 631439
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes.
    Yamamoto T; Raskin P; Aydin I; Unger R
    Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects.
    Prince RL; Larkins RG; Alford FP
    Metabolism; 1981 Mar; 30(3):293-8. PubMed ID: 7010074
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects.
    Bohannon NV; Lorenzi M; Grodsky GM; Karam JH
    J Clin Endocrinol Metab; 1982 Feb; 54(2):459-62. PubMed ID: 7054228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucagon-stimulated plasma c-peptide in diabetics. Clinical parameters in the choice of therapy?].
    Urdahl P; Jørgensen HS
    Tidsskr Nor Laegeforen; 1986 Jun; 106(16):1392-5. PubMed ID: 3529489
    [No Abstract]   [Full Text] [Related]  

  • 17. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
    Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E
    Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin, glucagon, and amino acids during glycemic control by the artificial pancreas in diabetic man.
    Hanna AK; Zinman B; Nakhooda AF; Minuk HL; Stokes EF; Albisser AM; Leibel BS; Marliss EB
    Metabolism; 1980 Apr; 29(4):321-32. PubMed ID: 6990172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose utilization during exercise in normal and diabetic subjects. The role of insulin.
    Krzentowski G; Pirnay F; Pallikarakis N; Luyckx AS; Lacroix M; Mosora F; Lefèbvre PJ
    Diabetes; 1981 Dec; 30(12):983-9. PubMed ID: 7030833
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of insulin therapy on the profiles of plasma immunoreactive glucagon in juvenile-type and adult-type diabetics.
    Raskin P; Unger RH
    Diabetes; 1978 Apr; 27(4):411-9. PubMed ID: 640246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.